Long-Term Follow-Up
Long-Term Follow-Up
Fred Hutch has two Long-Term Follow-Up (LTFU) programs focused on patients who have undergone a bone-marrow or stem-cell transplant and immunotherapy. Services for both programs are provided through the Hutch and the Seattle Cancer Care Alliance (SCCA).
COVID-19 (Coronavirus)
We understand that our BMT survivors may feel anxious about COVID-19. We are taking measures to make our clinic visits safe through additional screening and COVID-19 testing. We are following all guidance about personal protective equipment and additional cleaning and are confident that our actions are making a visit to the SCCA clinic safe for patients and staff. There are new practices in place that you will be asked to follow if you have an appointment.
If you have questions regarding how the current COVID-19 risk level impacts your LTFU upcoming or later appointment at Seattle Cancer Care Alliance (SCCA), call our LTFU Department (206) 667-4415 to discuss them with your care team.
Life-long Monitoring
Fred Hutch's Long-Term Follow-Up (LTFU) program provides life-long monitoring and care for patients following a bone-marrow or stem-cell transplant. Our physicians and researchers work in partnership with a patient's personal doctor to resolve medical problems and gather information for research. This information is used to develop improved strategies for preventing and treating the long-term effects of transplantation, and to educate patients about post-transplant problems.
Ongoing Monitoring and Care
Fred Hutch's Cellular Immunotherapy Long-Term Follow-Up (LTFU) program provides monitoring and care for patients following Cellular Immunotherapy. Our clinicians and researchers work in partnership with patients’ personal doctors and other healthcare providers to resolve medical problems that may develop after cellular immunotherapy and gather information for research.
2022 Blood and Marrow Transplant Reunion
We are excited to welcome you and your loved ones to campus to reconnect with your care teams and other survivors, hear about successes achieved in blood stem cell and marrow transplantation, discuss challenges people face post-transplant and — most of all — to celebrate with you.